Adorable, April Rose M.
HRN: 21-84-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2022
CEFUROXIME 750MG (VIAL)
08/24/2022
08/30/2022
IV
350mg
Q8Hrs
AGE With Mod Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes